3-O-{(1R)-1-[(1,3-dihydroxypropan-2-yl)oxy]-2-hydroxyethyl}-2,6-bis-O-{(1S)-1-[(1,3-dihydroxypropan-2-yl)oxy]-2-hydroxyethyl}-beta-D-Man-(1->4) -beta-D-GlcNAc-(1->4)-3-O-[(1S)-2-hydroxy-1-{[(2S)-1-hydroxypropan-2-yl]oxy}ethyl]-D-GlcNAc-yl group
3-o-{(1r)-1-[(1,3-dihydroxypropan-2-yl)oxy]-2-hydroxyethyl}-2,6-bis-o-{(1s)-1-[(1,3-dihydroxypropan-2-yl)oxy]-2-hydroxyethyl}-beta-d-man-(1->4) -beta-d-glcnac-(1->4)-3-o-[(1s)-2-hydroxy-1-{[(2s)-1-hydroxypropan-2-yl]oxy}ethyl]-d-glcnac-yl group
A trisaccharide glucosaminyl group resulting from periodate treatment of the <em>N</em>-glycan phytohemaglutinin(PHA). In the structure, the asterisk represents the point of attachment to an asparagine residue in the protein part of the originating glycoprotein.